Cargando…
Two Phase 1, Open‐Label, Single‐Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions
Bacterial vaginosis (BV) is the most common vaginal infection in reproductive‐age women and a significant risk factor for sexually transmitted diseases and pregnancy complications. Standard 5‐ to 7‐day antimicrobial treatments for BV are associated with high rates of recurrence and adverse events. S...
Autores principales: | Pentikis, Helen S., Adetoro, Nikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033001/ https://www.ncbi.nlm.nih.gov/pubmed/29125715 http://dx.doi.org/10.1002/cpdd.406 |
Ejemplares similares
-
An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis
por: Pentikis, Helen, et al.
Publicado: (2020) -
In vitro metabolic profile and drug‐drug interaction assessment of secnidazole, a high‐dose 5‐nitroimidazole antibiotic for the treatment of bacterial vaginosis
por: Pentikis, Helen S., et al.
Publicado: (2020) -
Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals
por: Darpo, Borje, et al.
Publicado: (2017) -
Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
por: Kim, Hyungsub, et al.
Publicado: (2018) -
Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
por: Lee, Moon Hee, et al.
Publicado: (2023)